Sansure Biotech Inc. (SHA:688289)
China flag China · Delayed Price · Currency is CNY
20.17
+0.32 (1.61%)
At close: Jan 23, 2026

Sansure Biotech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
222.17226.27348.171,9372,2432,617
Upgrade
Depreciation & Amortization
149.65149.65116.989.0753.9426.68
Upgrade
Other Amortization
20.9220.9219.878.355.011.99
Upgrade
Loss (Gain) From Sale of Assets
2.362.360.250.31-2.83-3.46
Upgrade
Asset Writedown & Restructuring Costs
-5.31-5.31-54.8821.692.422.49
Upgrade
Loss (Gain) From Sale of Investments
33.733.7-253.74-79.24-81.01-22.56
Upgrade
Provision & Write-off of Bad Debts
13.7113.714.9845.9618.49-
Upgrade
Other Operating Activities
-95.99-25.6-13.92271.8336.6445.83
Upgrade
Change in Accounts Receivable
153.01153.01376.54-496.51-304.14-419.38
Upgrade
Change in Inventory
36.4636.46-78.3-282.1-93.03-212.07
Upgrade
Change in Accounts Payable
-305.37-305.37-421.31,0223.12585.72
Upgrade
Change in Other Net Operating Assets
-27.17-27.17-42.1660.853.840.94
Upgrade
Operating Cash Flow
199.95274.4543.542,5591,8772,642
Upgrade
Operating Cash Flow Growth
-1.57%530.34%-98.30%36.33%-28.96%11692.86%
Upgrade
Capital Expenditures
-414.85-421.1-391.35-558.83-372.86-108.67
Upgrade
Sale of Property, Plant & Equipment
1.70.250.720.0115.946.37
Upgrade
Cash Acquisitions
-1.07-1.07-113-11.59--
Upgrade
Divestitures
--58.28----
Upgrade
Sale (Purchase) of Real Estate
----1.77-
Upgrade
Investment in Securities
-861.64363.671,791-642.46-834.95-1,630
Upgrade
Other Investing Activities
148.9714.61110.0346.1377.8816.33
Upgrade
Investing Cash Flow
-1,127-101.921,398-1,167-1,112-1,716
Upgrade
Short-Term Debt Issued
-----55
Upgrade
Long-Term Debt Issued
-403.1318---
Upgrade
Total Debt Issued
1,098403.1318--55
Upgrade
Short-Term Debt Repaid
-----55-
Upgrade
Long-Term Debt Repaid
--31.29-23.91-17.18-6.27-
Upgrade
Total Debt Repaid
-435.82-31.29-23.91-17.18-61.27-
Upgrade
Net Debt Issued (Repaid)
661.97371.84-5.91-17.18-61.2755
Upgrade
Issuance of Common Stock
21.4521.45---1,884
Upgrade
Repurchase of Common Stock
---122.73-257.41-200.01-
Upgrade
Common Dividends Paid
-333.4-268.4-400.46-656.93-439.89-301.27
Upgrade
Other Financing Activities
-16.787.616015.5712.58-27.88
Upgrade
Financing Cash Flow
333.24132.49-369.11-915.95-688.591,610
Upgrade
Foreign Exchange Rate Adjustments
4.17-00.34-10.01-34.25-44.59
Upgrade
Net Cash Flow
-589.53305.011,073466.2442.012,492
Upgrade
Free Cash Flow
-214.9-146.66-347.812,0001,5042,534
Upgrade
Free Cash Flow Growth
---32.97%-40.63%-
Upgrade
Free Cash Flow Margin
-12.87%-10.06%-34.53%31.01%33.32%53.19%
Upgrade
Free Cash Flow Per Share
-0.32-0.25-0.593.422.564.59
Upgrade
Cash Interest Paid
----0.32-
Upgrade
Cash Income Tax Paid
109.91112.34121.48493.44466.25416.33
Upgrade
Levered Free Cash Flow
31.57-206.02-227.681,293898.551,780
Upgrade
Unlevered Free Cash Flow
43.55-194.52-226.171,295899.061,780
Upgrade
Change in Working Capital
-141.26-141.26-124.08264.17-398.29-49.44
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.